Eur J Pediatr Surg 2022; 32(01): 085-090
DOI: 10.1055/s-0041-1740461
Original Article

Review of Perioperative Prophylactic Antibiotic Use during Laparoscopic Cholecystectomy and Subsequent Surgical Site Infection Development at a Single Children's Hospital

1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Wendy Jo Svetanoff
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Jessica K. Staszak
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Charles L. Snyder
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Pablo Aguayo
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
David Juang
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Richard J. Hendrickson
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Jason D. Fraser
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Shawn D. St Peter
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
,
Tolulope A. Oyetunji
1   Department of Pediatric Surgery, Children's Mercy Hospital, Kansas City, Missouri, United States
› Author Affiliations

Abstract

Objectives With the rise of antibiotic resistance, the use of prophylactic preoperative antibiotics (PPA) has been questioned in cases with low rates of surgical site infection (SSI). We report PPA usage and SSI rates after elective laparoscopic cholecystectomy at our institution.

Materials and Methods A retrospective review of children younger than 18 years who underwent elective outpatient laparoscopic cholecystectomy between July 2010 and August 2020 was performed. Demographic, preoperative work-up, antibiotic use, intraoperative characteristics, and SSI data were collected via chart review. SSI was defined as clinical signs of infection that required antibiotics within 30 days of surgery.

Results A total of 502 patients met the inclusion criteria; 50% were preoperatively diagnosed with symptomatic cholelithiasis, 47% with biliary dyskinesia, 2% with hyperkinetic gallbladder, and 1% with gallbladder polyp(s). The majority were female (78%) and Caucasian (80%). In total, 60% (n = 301) of patients received PPA, while 40% (n = 201) did not; 1.3% (n = 4) of those who received PPA developed SSI, compared with 5.5% (n = 11) of those who did not receive PPA (p = 0.01). Though PPA use was associated with a 77% reduction in the risk of SSI in multivariate analysis (p = 0.01), all SSIs were superficial. One child required readmission for intravenous antibiotics, while the remainder were treated with outpatient antibiotics. Gender, age, body mass index, ethnicity, and preoperative diagnosis did not influence the likelihood of receiving PPA.

Conclusion Given the relatively low morbidity of the superficial SSI, conservative use of PPA is advised to avoid contributing to antibiotic resistance.



Publication History

Received: 18 July 2021

Accepted: 21 October 2021

Article published online:
23 December 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Iskandar K, Sartelli M, Tabbal M. et al. Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial-resistant bacteria. World J Emerg Surg 2019; 14: 50
  • 2 Cosgrove SE. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis 2006; 42 (Suppl. 02) S82-S89
  • 3 Urban JA. Cost analysis of surgical site infections. Surg Infect (Larchmt) 2006; 7 (Suppl. 01) S19-S22
  • 4 Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43 (03) 322-330
  • 5 Cataife G, Weinberg DA, Wong HH, Kahn KL. The effect of Surgical Care Improvement Project (SCIP) compliance on surgical site infections (SSI). Med Care 2014; 52 (2, Suppl 1): S66-S73
  • 6 Septimus EJ. Antimicrobial resistance: an antimicrobial/diagnostic stewardship and infection prevention approach. Med Clin North Am 2018; 102 (05) 819-829
  • 7 Williams K, Baumann L, Abdullah F, St Peter SD, Oyetunji TA. Variation in prophylactic antibiotic use for laparoscopic cholecystectomy: need for better stewardship in pediatric surgery. J Pediatr Surg 2017;S0022–3468(17)30634–30636. doi: 10.1016/j.jpedsurg.2017.10.012 (Epub ahead of print) PMID: 29106917
  • 8 Choudhary A, Bechtold ML, Puli SR, Othman MO, Roy PK. Role of prophylactic antibiotics in laparoscopic cholecystectomy: a meta-analysis. J Gastrointest Surg 2008; 12 (11) 1847-1853 , discussion 1853
  • 9 Yan RC, Shen SQ, Chen ZB, Lin FS, Riley J. The role of prophylactic antibiotics in laparoscopic cholecystectomy in preventing postoperative infection: a meta-analysis. J Laparoendosc Adv Surg Tech A 2011; 21 (04) 301-306
  • 10 Pasquali S, Boal M, Griffiths EA, Alderson D, Vohra RS. CholeS Study Group, West Midlands Research Collaborative. Meta-analysis of perioperative antibiotics in patients undergoing laparoscopic cholecystectomy. Br J Surg 2016; 103 (01) 27-34 , discussion 34
  • 11 Liang B, Dai M, Zou Z. Safety and efficacy of antibiotic prophylaxis in patients undergoing elective laparoscopic cholecystectomy: a systematic review and meta-analysis. J Gastroenterol Hepatol 2016; 31 (05) 921-928
  • 12 Sømme S, Bronsert M, Morrato E, Ziegler M. Frequency and variety of inpatient pediatric surgical procedures in the United States. Pediatrics 2013; 132 (06) e1466-e1472
  • 13 Rangel SJ, Fung M, Graham DA, Ma L, Nelson CP, Sandora TJ. Recent trends in the use of antibiotic prophylaxis in pediatric surgery. J Pediatr Surg 2011; 46 (02) 366-371
  • 14 Smith JP, Samra NS, Ballard DH, Moss JB, Griffen FD. Prophylactic antibiotics for elective laparoscopic cholecystectomy. Am Surg 2018; 84 (04) 576-580
  • 15 Bratzler DW, Dellinger EP, Olsen KM. et al; American Society of Health-System Pharmacists, Infectious Disease Society of America, Surgical Infection Society, Society for Healthcare Epidemiology of America. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013; 70 (03) 195-283
  • 16 Meijer WS, Schmitz PIM, Jeekel J. Meta-analysis of randomized, controlled clinical trials of antibiotic prophylaxis in biliary tract surgery. Br J Surg 1990; 77 (03) 283-290
  • 17 Kelkar PS, Li JT. Cephalosporin allergy. N Engl J Med 2001; 345 (11) 804-809
  • 18 Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46 (12) 1838-1843
  • 19 Kadri SS. Key takeaways from the U.S. CDC's 2019 Antibiotic Resistance Threats Report for frontline providers. Crit Care Med 2020; 48 (07) 939-945
  • 20 Chang WT, Lee KT, Chuang SC. et al. The impact of prophylactic antibiotics on postoperative infection complication in elective laparoscopic cholecystectomy: a prospective randomized study. Am J Surg 2006; 191 (06) 721-725
  • 21 Higgins A, London J, Charland S. et al. Prophylactic antibiotics for elective laparoscopic cholecystectomy: are they necessary?. Arch Surg 1999; 134 (06) 611-613 , discussion 614